Climb Bio

(NASDAQ) CLYM

Current Price$11.20

Market Cap$641.32M

Since IPO (2021)-30%

5 YearN/A

1 Year+849%

1 Month+26%

Climb Bio Financials at a Glance

Market Cap

$641.32M

Revenue (TTM)

$0.00

Net Income (TTM)

-$52.79M

EPS (TTM)

-$0.78

P/E Ratio

-14.38

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Price

$11.20

Volume

1,424,651.724

Open

$11.75

Price

$11.20

Volume

1,424,651.724

Open

$11.75

Previous Close

$11.20

Daily Range

$10.65 - $11.75

52-Week Range

$1.16 - $12.48

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Price

$11.20

Volume

1,424,651.724

Open

$11.75

Previous Close

$11.20

Daily Range

$10.65 - $11.75

52-Week Range

$1.16 - $12.48

CLYM News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Climb Bio

Industry

Biotechnology

Sector

Health Care

Employees

CEO

Aoife M. Brennan, MD

Website

www.climbbio.com

Headquarters

Wellesley Hills, DE 19808-1609, US

CLYM Financials

Key Financial Metrics (TTM)

Gross Margin

Operating Margin

Net Income Margin

Return on Equity

-31%

Return on Capital

-41%

Return on Assets

-35%

Earnings Yield

-6.95%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$641.32M

Shares Outstanding

57.26M

Volume

1.42M

Avg. Volume

729.21K

Financials (TTM)

Gross Profit

-$97.00K

Operating Income

-$67.88M

EBITDA

-$67.79M

Operating Cash Flow

-$54.36M

Capital Expenditure

-$186.00K

Free Cash Flow

-$54.54M

Cash & ST Invst.

$101.08M

Total Debt

$541.00K

Climb Bio Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$0.00

N/A

Gross Profit

-$38.00K

N/A

Gross Margin

0.00%

N/A

Market Cap

$641.32M

N/A

Market Cap/Employee

$37.72M

N/A

Employees

N/A

Net Income

-$13.72M

+34.0%

EBITDA

-$15.17M

+34.1%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Net Cash

$109.09M

+11.8%

Accounts Receivable

$0.00

-100.0%

Inventory

$0.00

N/A

Long Term Debt

$216.00K

-32.3%

Short Term Debt

$263.00K

+69.7%

Return on Assets

-34.65%

N/A

Return on Invested Capital

-40.51%

N/A

Free Cash Flow

-$14.38M

+6.8%

Operating Cash Flow

-$14.38M

+6.8%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

TTRXTurn Therapeutics Inc.

TTRXTurn Therapeutics Inc.$6.42+1.42%

SPROSpero Therapeutics, Inc.

SPROSpero Therapeutics, Inc.$2.83+0.00%

ABOSAcumen Pharmaceuticals, Inc.

ABOSAcumen Pharmaceuticals, Inc.$2.37-5.58%

AGENAgenus Inc.

AGENAgenus Inc.$3.38-2.87%

ANIXAnixa Biosciences, Inc.

ANIXAnixa Biosciences, Inc.$2.55-5.56%

MCRBSeres Therapeutics, Inc.

MCRBSeres Therapeutics, Inc.$7.33-4.06%

INOInovio Pharmaceuticals, Inc.

INOInovio Pharmaceuticals, Inc.$1.21-5.47%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

NUNu Holdings

NUNu Holdings$11.93-0.08%

NOKNokia

NOKNokia$16.85+0.04%

ONDSOndas

ONDSOndas$13.58+0.01%

SOFISoFi Technologies

SOFISoFi Technologies$17.74-0.05%

IBITiShares Bitcoin Trust

IBITiShares Bitcoin Trust$38.05-0.06%

RGTIRigetti Computing

RGTIRigetti Computing$26.88+0.05%

FFord Motor Company

FFord Motor Company$16.15-0.03%

Questions About CLYM

What is the current price of Climb Bio?

Climb Bio is trading at $11.20 per share.

What is the 52-week range for Climb Bio?

Over the past 52 weeks, Climb Bio has traded between $1.16 and $12.48.

How much debt does Climb Bio have?

As of the most recent reporting period, Climb Bio reported total debt of $479.00K.

How much cash does Climb Bio have on hand?

Climb Bio reported $8.36M in cash and cash equivalents in its most recent financial results.

What is Climb Bio’s dividend yield?

Climb Bio does not currently have a dividend yield.

Climb Bio

Climb Bio Financials at a Glance

CLYM News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Climb Bio

CLYM Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Climb Bio Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About CLYM

What is the current price of Climb Bio?

What is the 52-week range for Climb Bio?

How much debt does Climb Bio have?

How much cash does Climb Bio have on hand?

What is Climb Bio’s dividend yield?

Premium Investing Services